WallStSmart
ARWR

Arrowhead Pharmaceuticals Inc

NASDAQ: ARWR · HEALTHCARE · BIOTECHNOLOGY

$73.48
+4.18% today

Updated 2026-04-30

Market cap
$9.88B
P/E ratio
44.08
P/S ratio
9.05x
EPS (TTM)
$1.60
Dividend yield
52W range
$12 – $77
Volume
2.2M

Arrowhead Pharmaceuticals Inc (ARWR) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Revenue$595458.00$1.21M$1.30M$3.76M$620097.00$296139.00$146875.00$290266.00$175000.00$382000.00$158333.00$31.41M$16.14M$168.80M$87.99M$138.29M$243.23M$240.74M$3.55M$829.45M
Revenue growth (YoY)+102.9%+7.9%+188.4%-83.5%-52.2%-50.4%+97.6%-39.7%+118.3%-58.6%+19736.5%-48.6%+945.7%-47.9%+57.2%+75.9%-1.0%-98.5%+23258.2%
Cost of revenue$7.36M$11.78M$14.85M$9.03M$4.95M$267977.00$1.75M$20.40M$47.56M$81.98M$82.45M$63.71M$67.38M$10.42M$12.49M$18.59M$23.93M
Gross profit$-6.76M$-10.57M$-13.55M$-5.26M$-4.33M$28162.00$-1.60M$290266.00$175000.00$382000.00$158333.00$31.41M$16.14M$168.80M$87.99M$138.29M$243.23M$228.24M$-15.04M$805.52M
Gross margin-1135.7%-874.8%-1039.8%-139.9%-698.7%9.5%-1090.8%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%94.8%-423.7%97.1%
R&D$8.58M$10.94M$8.31M$6.21M$857409.00$3.28M$5.39M$8.71M$23.14M$47.27M$41.45M$46.25M$48.30M$76.63M$123.54M$198.98M$297.31M$342.31M$489.22M$585.26M
SG&A$5.03B$4.39B$6.85B$14.04M$8.00M$6.58M$14.10M$11.69M$24.42M$34.72M$23.59M$17.50M$19.11M$26.56M$52.28M$80.98M$124.43M$90.93M$96.82M$123.94M
Operating income$-20.48M$-37.95M$-35.00M$-19.56M$-8.80M$-9.83M$-21.09M$-24.59M$-53.28M$-95.97M$-81.74M$-37.00M$-55.94M$61.19M$-93.16M$-149.04M$-178.51M$-205.00M$-601.08M$98.35M
Operating margin-3439.9%-3141.4%-2685.9%-520.5%-1419.5%-3319.5%-14358.6%-8471.3%-30443.6%-25124.1%-51627.1%-117.8%-346.5%36.3%-105.9%-107.8%-73.4%-85.2%-16927.1%11.9%
EBITDA$-19.60M$-36.95M$-33.87M$-18.57M$-9.83M$-9.56M$-19.34M$-21.53M$-49.76M$-93.64M$-76.43M$-32.31M$-51.24M$65.63M$-87.22M$-132.58M$-168.09M$-175.67M$-561.51M$164.82M
EBITDA margin-3291.0%-3058.3%-2598.9%-494.0%-1585.7%-3229.0%-13167.8%-7417.3%-28433.3%-24512.5%-48272.9%-102.9%-317.4%38.9%-99.1%-95.9%-69.1%-73.0%-15812.8%19.9%
EBIT$-20.48M$-37.95M$-35.00M$-19.56M$-10.49M$-9.83M$-21.09M$-23.28M$-51.10M$-95.97M$-79.69M$-37.00M$-55.94M$61.19M$-93.16M$-140.85M$-178.51M$-188.16M$-580.11M$140.89M
Interest expense$0.00$0.00$0.00$150891.00$48.02M$86.53M$35.97M$97910.00$645.49M$729.16M$265.79M$415.13M$1.05B$6.96B$9.19B$6.12M$5.03M$18.33M$32.35M$89.36M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-19.00M$-29.93M$-27.09M$-19.31M$-5.77M$-3.13M$-21.13M$-31.14M$-58.63M$-91.94M$-81.72M$-34.38M$-54.45M$67.97M$-84.55M$-140.85M$-176.49M$-205.28M$-599.49M$-1.63M
Net income growth (YoY)-57.6%+9.5%+28.7%+70.1%+45.8%-575.2%-47.4%-88.3%-56.8%+11.1%+57.9%-58.4%+224.8%-224.4%-66.6%-25.3%-16.3%-192.0%+99.7%
Profit margin-3190.4%-2477.7%-2078.7%-513.8%-931.2%-1056.6%-14383.6%-10729.2%-33503.0%-24068.3%-51614.6%-109.5%-337.3%40.3%-96.1%-101.9%-72.6%-85.3%-16882.4%-0.2%